Androgen Replacement Therapy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

Androgen Replacement Therapy Market is poised to value over USD 3.3 billion by 2028 end at a CAGR of over 7% during the forecast period 2022 to 2028.

Androgen replacement therapy, or low testosterone therapy, is commonly referred to as hormone replacement therapy in men. It is designed to counteract the effects of reduced gonad activity or hypogonadism. Hypogonadism in men is a clinical syndrome in which the testes fail to produce physiological levels of testosterone. The main cause of hypogonadism may be a problem with the testicles. A secondary cause is a problem with the hypothalamus or pituitary gland, or both primary and secondary. Primary hypogonadism is caused by genetic abnormalities, testicular trauma, orchitis, radiation therapy or chemotherapy, and secondary hypogonadism is caused by genetic abnormalities of the pituitary gland and hypothalamus. Testosterone injections, implants, gels, creams, and oral medications are used to treat hypogonadism.

Market Segments

By Product Type:

• Testosterone Creams/Gels
• Testosterone Patches
• Testosterone Injections
• Testosterone Implants
• Testosterone Tablets/Capsules/Gums

By Active Ingredient Type:

• Testosterone
• Methyl Testosterone
• Testosterone Undecanoate
• Testosterone Enanthate
• Testosterone Cypionate

Key Players

Key players operating in the global androgen replacement therapy market include AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Plc., Eli Lilly and Company, Kyowa Kirin International Plc., Novartis International AG, Pfizer Inc., Clarus Therapeutics, Inc., Perrigo Company Plc, Acerus Pharmaceuticals Corporation, Sawai pharmaceutical Co., Ltd., Reddy’s Laboratories, Sun Pharmaceutical Industries Ltd., and Simple Pharma.

Scope of the Report

The research study analyzes the global Androgen Replacement Therapy industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Androgen Replacement Therapy Market Report

1. What was the Androgen Replacement Therapy Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Androgen Replacement Therapy Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Androgen Replacement Therapy Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.